What is the recommended diagnostic workup and treatment for avascular necrosis?

Avascular Necrosis: Diagnostic Workup and Treatment

Initial Diagnostic Approach

Begin with plain radiographs of the affected joint in two planes as the first-line imaging study, even though they have limited sensitivity for early disease, because they effectively exclude other causes of pain such as fracture, primary arthritis, or tumor. 1

Imaging Algorithm

• Plain radiography is the initial study for all suspected cases, regardless of body region (hip, shoulder, knee, ankle, wrist) 1
• MRI is the most sensitive diagnostic modality and should be performed when clinical suspicion exists with normal radiographs, particularly in young patients with unexplained hip or shoulder pain 1, 2
• CT scanning is particularly useful to exclude subchondral fractures and can detect previously underreported cases of osteonecrosis 1
• Bone scintigraphy has restricted use and is reserved for exceptional cases only 2

Key Clinical Features to Identify

• Age: Most commonly affects adults in their third to fifth decades of life 1
• Pain location: Hip pain with referred knee pain is the classic presentation for femoral head involvement 2
• Risk factors requiring systematic evaluation include:
  • Corticosteroid therapy (most important modifiable factor) 1, 3
  • Alcohol abuse 1, 4
  • Trauma 1, 3
  • Sickle cell disease 4, 3
  • HIV, lymphoma/leukemia, blood dyscrasias 1
  • Hypercholesterolemia 4
  • Gaucher disease, Caisson disease 1

Bilateral and Multifocal Assessment

• In nontraumatic femoral head cases, 70-80% are bilateral 1
• When osteonecrosis is found at one site, evaluate for multifocal involvement: hip (68%), knee (44%), ankle (17%), and shoulder (15%) 1

Staging and Prognosis

Use the ARCO (Association Research Circulation Osseous) classification system, which is widely accepted in Europe and accounts for lesion size and location, unlike the older Ficat-Arlet system. 1, 2

Critical Prognostic Factors

• Necrotic volume >30% of the femoral head progresses to collapse in 46-83% of cases, versus <5% collapse rate when necrotic volume is <30% 1
• Humeral head necrotic angle <90 degrees does not collapse within 24 months 1
• Risk factors for femoral head collapse include: joint effusion, bone marrow edema around the necrotic focus, age >40 years, and BMI >24 kg/m² 1
• Epiphyseal osteonecrosis (femoral head, humeral head, talus) leads to subchondral fracture and secondary osteoarthritis, while metadiaphyseal cases do not progress to joint destruction 1

Treatment Strategy

Early Stage Disease (ARCO I-II, Pre-Collapse)

For ARCO stage I (reversible early stage) or stage II (irreversible early stage) with medial or central necrosis involving <30% of the femoral head, perform core decompression, which shows better results than conservative therapy. 5

Joint-Preserving Surgical Options

• Core decompression is the primary intervention for early-stage disease and can be performed in the femoral head, humeral head, and talus 1, 5
• Core decompression can be supplemented with autologous bone marrow cells, vascularized fibular grafting, or electrical stimulation, though overall efficacy at preventing eventual collapse remains controversial 1
• For ARCO stage III with femoral head infraction, core decompression provides only short-term pain relief 5
• Additional procedures (osteotomies, bone grafting) can be considered on an individual basis, but note that previous joint-preserving surgery, particularly osteotomies and grafts, significantly complicates subsequent total hip arthroplasty 5

Medical Management

Noninvasive therapies have limited supporting data but include:

• Statins 1
• Bisphosphonates 1
• Anticoagulants 1
• Extracorporeal shock wave therapy 1
• Hyperbaric oxygen 1
• Risk factor management (discontinue corticosteroids when possible, reduce alcohol intake, weight reduction) 4, 3
• Physical therapy and anti-inflammatory medications 3

Late Stage Disease (ARCO III-IV, Post-Collapse)

For ARCO stage IIIC or stage IV, do not perform core decompression; instead, proceed directly to arthroplasty evaluation. 5

Arthroplasty Options

• For late-stage femoral or humeral head osteonecrosis with articular collapse, resurfacing hemiarthroplasty may be indicated 1
• Total joint arthroplasty is performed for severe secondary osteoarthritis 1
• Both cemented and cementless fixation techniques achieve good results comparable to those for coxarthrosis 5
• For humeral head AVN, pyrocarbon hemiarthroplasty may reduce glenoid erosion compared to traditional materials 6
• For late-stage talar osteonecrosis, perform talar resection/replacement with arthroplasty or tibiotalar joint fusion 1

Special Considerations

• Femoral head osteonecrosis accounts for 10% of total hip replacement indications in the United States 1
• Higher revision rates are expected in sickle cell disease, Gaucher disease, and kidney transplantation patients 5
• The relatively young age of patients with avascular necrosis (average 33-38 years) represents the main risk factor for higher revision rates 5, 7

Critical Pitfalls to Avoid

• Do not rely solely on radiographs in young patients with joint pain and risk factors—proceed directly to MRI 1, 2
• Do not perform core decompression in ARCO stage IIIC or IV disease, as it will not prevent progression and complicates future arthroplasty 5
• Do not overlook bilateral hip involvement in nontraumatic cases—image both hips 1
• Do not miss multifocal disease—when one site is identified, systematically evaluate other common sites 1
• Avoid intra-articular corticosteroid injections in the hip, as AVN incidence ranges from 0.6-20.4% following this procedure, with risk factors including elevated BMI, cancer therapy history, low vitamin D, and multiple injections 8